Homarylamine (INN;[1] also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is an antitussive (anti-cough) drug[2] which was patented in 1956 by Merck & Co.,[3] but has never been used medically as such.
Chemically it is a substituted phenethylamine. It is the N-methylated analog of methylenedioxyphenethylamine (MDPEA). It is a schedule I drug in the USA as a positional isomer of MDA.
^"International Non-Proprietary Names for Pharmaceutical Preparations" (PDF). Chronicle of the World Health Organization. 12 (3). 1958.
^Stefko PL, Denzel J, Hickey I (March 1961). "Experimental Investigation of Nine Antitussive Drugs". Journal of Pharmaceutical Sciences. 50 (3): 216–221. doi:10.1002/jps.2600500309.
Homarylamine (INN; also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is an antitussive (anti-cough) drug which was patented in 1956 by...
exact mass : 179.094629) may refer to: ALPHA (psychedelic) Fusaric acid Homarylamine (methylenedioxymethylphenethylamine) 2,3-Methylenedioxyamphetamine (2...
phenethylamine alkaloid found in Lophophora williamsii. Less functionalized Homarylamine 3,4-Methylenedioxyphenethylamine More functionalised Methylenedioxydimethylamphetamine...